Earning Analysis
Welcome to our in-depth analysis of Outlook Therapeutics Inc(OTLK) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Outlook Therapeutics Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
OTLK Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Outlook Therapeutics Inc reported performance for , announced on 2025-08-13. The company achieved an EPS of , compared to analyst estimates of -0.42 by % . Revenue for the quarter reached 0.00 compared to expectations of 2.55M by % .
The stock price reacted with a 14.08% one-day change and a 23.47% five-day change following the earnings release. These movements reflect market reaction in Outlook Therapeutics Inc growth trajectory and strategic initiatives.
OTLK Earnings Forecast
Looking ahead, Outlook Therapeutics Inc(OTLK) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 5.85M and an EPS of -0.18.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been Revise Downward by -15.71%, while EPS estimates have been No Change by 0%. For the upcoming Q1 2026, revenue estimates have been adjusted Revise Upward by 156.67% . These revisions correlate with a -48.49% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Outlook Therapeutics Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between OTLK's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2026
Revise Downward
-15.71%
In Past 3 Month
EPS Estimates for FY2026
No Change
0.00%
In Past 3 Month
Revenue Estimates for Q1 2026
Revise Upward
+156.67%
In Past 3 Month
Stock Price
Go Down
-48.49%
In Past 3 Month
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2026:11.80M
--
EPS Estimate-Annual FY 2026:-1.04
—
Stock Price0.60
OTLK Revenue and EPS Performance: A Historical Perspective
Outlook Therapeutics Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2025-08-13,After Hours):
EPS: (Actual) vs.-0.42 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 2.55M (Estimate) (%)
Price Reaction: 14.08%(1-Day), 23.47%(5-Day)
FY2025Q2 (2025-05-15,After Hours):
EPS: -0.40 (Actual) vs.-0.55 (Estimate) (27.27%)
Revenue: 0.00 (Actual) vs. 702.60K (Estimate) (-100.00%)
Price Reaction: 4.48%(1-Day), -2.69%(5-Day)
FY2024Q4 (2024-12-27,):
EPS: (Actual) vs.-0.83 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 18.24%(1-Day), 31.76%(5-Day)
Earnings Reaction
The chart below shows how OTLK performed 10 days before and after its earnings report, based on data from the past quarters. Typically, OTLK sees a -3.27% change in stock price 10 days leading up to the earnings, and a +5.60% change 10 days following the report. On the earnings day itself, the stock moves by +2.39%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed 14.08% on the day following the earnings release and then changed by 11.50% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
People Also Watch
Frequently Asked Questions
What were the key highlights of OTLK's latest earnings report for ?
OTLK reported its earnings on 2025-08-13, showcasing a revenue of 0.00 against an estimate of 2.55M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.42 by 0% . The stock experienced a 14.08% price change on the earnings day and a 23.47% change over the next five days, reflecting market reactions to the results.
How did OTLK's stock price react after the earnings release?
Following OTLK's earnings announcement on 2025-08-13, the stock price moved by 14.08% on the day of the release. Over the subsequent five days, it saw a 23.47% change. Historically, OTLK's stock price tends to shift by an average of -3.27% in the 10 days leading up to earnings and +5.60% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for OTLK for 2025/Q4?
For 2025/Q4, analysts estimate OTLK’s annual revenue to reach 5.85M, while the EPS is projected at -0.18. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -15.71% and EPS estimates Revise Upward by 156.67% over the past three months, indicating analyst expectation in the company’s performance.
How does OTLK's stock price correlate with earnings forecast revisions?
The correlation between OTLK's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Downward by -15.71%, while EPS estimates moved Revise Upward by 156.67% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from OTLK's next earnings report?
Based on historical trends, OTLK's stock price typically moves by -3.27% in the 10 days before its earnings and +5.60% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.18 and revenue of 5.85M.
What is the sentiment in Outlook Therapeutics, Inc. (OTLK) Q3 2024 Earnings Call Summary?
The earnings call presents a mixed outlook. Positive aspects include a reduction in net loss, ongoing clinical trials, and expected EU approval. However, regulatory, clinical trial, and financial risks pose significant uncertainties. The Q&A section highlights potential delays in BLA resubmission and unclear details on UK market access, which are concerns. The absence of strong catalysts like new partnerships or record revenues tempers any positive sentiment. Thus, the overall sentiment remains neutral, as potential gains are balanced by risks and uncertainties.